The phenotypic and functional characteristics of natural killer (NK) cells in chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are incompletely defined and largely controversial. METHODS: We studied NK cell receptor expression, cytotoxic activity, and cytokine production in peripheral blood mononuclear cells from 35 patients with chronic hepatitis C, 22 with chronic hepatitis B, and 30 healthy controls. RESULTS: Patients with chronic HBV infection had an increased proportion of NKG2C ϩ NK cells with normal inhibitory receptor expression and a lower proportion of activated NK cells compared with HCV ϩ patients, which was associated with normal or reduced cytolytic activity and markedly dysfunctional tumor necrosis factor-␣ and interferon-␥ production. Patients with chronic HCV infection showed a predominantly activating phenotype, featuring a decreased percentage of cells expressing the inhibitory receptor KIR3DL1 and a concomitant increase in the proportion of NKG2D ϩ NK cells. Expression of the CD69 early activation antigen on NK cells positively correlated with serum alanine aminotransferase and HCV RNA values, suggesting participation of virus-induced effector NK cells in liver necroinflammation. Phenotypic changes in HCV ϩ patients were associated with enhanced cytokine-induced cytolytic activity and increased usage of natural cytotoxicity and NKG2D receptor pathways, accompanied by defective cytokine production, although to a lesser extent than patients with chronic HBV infection. CONCLU-SIONS: These findings provide evidence for a functional dichotomy in patients with chronic HBV and HCV infections, featuring conserved or enhanced cytolytic activity and dysfunctional cytokine production, which may contribute to virus persistence.
BACKGROUND & AIMS:
The phenotypic and functional characteristics of natural killer (NK) cells in chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are incompletely defined and largely controversial. METHODS: We studied NK cell receptor expression, cytotoxic activity, and cytokine production in peripheral blood mononuclear cells from 35 patients with chronic hepatitis C, 22 with chronic hepatitis B, and 30 healthy controls. RESULTS: Patients with chronic HBV infection had an increased proportion of NKG2C ϩ NK cells with normal inhibitory receptor expression and a lower proportion of activated NK cells compared with HCV ϩ patients, which was associated with normal or reduced cytolytic activity and markedly dysfunctional tumor necrosis factor-␣ and interferon-␥ production. Patients with chronic HCV infection showed a predominantly activating phenotype, featuring a decreased percentage of cells expressing the inhibitory receptor KIR3DL1 and a concomitant increase in the proportion of NKG2D ϩ NK cells. Expression of the CD69 early activation antigen on NK cells positively correlated with serum alanine aminotransferase and HCV RNA values, suggesting participation of virus-induced effector NK cells in liver necroinflammation. Phenotypic changes in HCV ϩ patients were associated with enhanced cytokine-induced cytolytic activity and increased usage of natural cytotoxicity and NKG2D receptor pathways, accompanied by defective cytokine production, although to a lesser extent than patients with chronic HBV infection. CONCLU-SIONS: These findings provide evidence for a functional dichotomy in patients with chronic HBV and HCV infections, featuring conserved or enhanced cytolytic activity and dysfunctional cytokine production, which may contribute to virus persistence. S tudies on early immune defense mechanisms showed that hepatitis B virus (HBV) infection does not induce appreciable changes in innate immune response genes in the first weeks of infection, whereas hepatitis C virus (HCV) efficiently induces interferon (IFN)␣/␤-response genes. 1 However, available evidence suggests that HCV eludes innate cellular defense mechanisms by blocking IFN-signaling pathways. [2] [3] [4] [5] Interestingly, despite the apparent silence of IFN␣/␤ response genes in HBV-infected chimpanzees, there is evidence of natural killer T (NKT) cell activation in the transgenic mouse model of HBV infection, which can inhibit virus replication via IFN-␥ production, 6 and, in addition, NKT cells can be triggered during HBV infection by the expression of stress signals on infected hepatocytes recognized by natural killer cell receptors (NKRs). 7 NK cells are important antiviral effectors of innate immunity because of their contribution to virus elimination via direct killing of infected cells and cytokine (IFN-␥ and tumor necrosis factor [TNF]-␣) production, and their regulation depends on a fine balance between inhibitory and activating receptors (NKRs). 8 -10 Preferential expression of the inhibitory receptor KIR2DL3 on NK cells has been reported in patients with a self-limited outcome of acute HCV infection acquired by a low-dose exposure. 11 However, the real impact of these mechanisms on NK cell function is unknown because phenotypic changes do not necessarily reflect altered function. 12, 13 The observations that the interaction of the E2 protein of HCV with CD81 on NK cells inhibits their activation 14, 15 and that NK cell functions can be deficient in individuals chronically infected with HCV 16 -29 suggest that HCV may actually contribute to impair the NK cell response, although the data are still controversial. 20 In the present study, we have performed an extended phenotypic analysis of peripheral blood NK cells in chronic HBV and HCV infections by determining activating and inhibitory NKR expression. In addition, we examined NK cytolytic potential and cytokine production in the presence or absence of cytokine stimulation. We show that NK cells from patients with chronic HBV and chronic HCV infections differ in NKR expression and that NK function is characterized by a conserved or enhanced cytolytic activity and a dysfunctional cytokine production. This defect may be an important mechanism contributing to virus persistence. 
Materials and Methods

Isolation and Storage of Peripheral Blood Mononuclear Cells
Cell Surface Staining and Flow Cytometry Analysis
NKR phenotype was carried out as previously described. 21 NK cells were identified in PBMC as CD3 Ϫ / CD20 Ϫ /CD56 ϩ and could be easily defined as CD56 dim and CD56 bright according to fluorescence intensity. Expression of several activating (NKG2D, CD94/NKG2C, NKp44, NKp46, and NKp30) and inhibitory (IRP60, CD94/NKG2A, KIR2DL1, KIR2DL2, KIR3DL1, LIR1/ ILT2, p75/AIRM1) NKRs, as well as coreceptors (2B4, NTB-A, NKp80, DNAM.1) and early activation molecules (CD69) was examined by labelling with monoclonal antibodies (mAbs) as described previously. 21 In addition, a detailed analysis of single inhibitory receptor expression was carried out using PE-conjugated IgG1 mAbs specific for KIR2DL2/DL3/DS2 (CD158 b1,b2,j), KIR2DL1/DS1 (CD158 a,h), KIR3DL1/DS1 (Z27, CD158 e1,e2), and ILT2 (CD85), all from Beckman Coulter, Fullerton, CA. Flow cytometry analysis was performed using a 2 laser FACSCalibur instrument equipped with CellQuest Pro software (BD Bioscience).
Cytokine Production by Intracellular Staining
Intracellular staining (ICS) was carried out as described elsewhere, 22 with minor modifications. TNF-␣ and IFN-␥ production by NK cells was tested by ICS after overnight stimulation of PBMC with different combinations of cytokines: interleukin (IL)-2 (100 U/mL; Biosource, Camarillo, CA) ϩ IL-12 (0.5 ng/mL; R&D System, Minneapolis, MN) and IL-2 (100 U/mL) ϩ IL-21 (100 ng/mL; Biosource). IL-21 was used in cytokine combinations because it was shown to efficiently stimulate IFN-␥ production by NK cells 23, 24 and was as effective or more than IL-15 in stimulating CD107a degranulation and cytokine production as shown by preliminary experiments (Supplementary Figure 1A-D) . After stimulation, PBMCs were plated at 2 ϫ 10 5 cells/well with GolgiStop solution (BD Biosciences, San Jose, CA) in 96 well flat bottom plates coated with 10 g/mL anti-CD16 (Fc␥RIII) IgM antibody (Immunological Sciences, Rome, Italy). CD16 engagement on CD56 bright cells is a secondary signal required for IFN-␥ production, 25 and CD16 expression on these cells was shown to increase 3-to 4-fold following stimulation with the cytokine combinations employed in this study (Supplementary Figure  2) . Unstimulated PBMCs and uncoated plates served as negative controls. After 4-hour incubation at 37°C, cells were harvested, washed with phosphate-buffered saline (PBS) 2% fetal bovin serum (FBS), and stained for 30 minutes at 4°C with directly conjugated anti-CD56 PC5, anti-CD19 PE, and anti-CD3 FITC antibodies. Next, PBMCs were washed, fixed, and permeabilized by BD Cytofix/Cytoperm Solution (BD Biosciences) according to the manufacturer's instructions and stained with anti-IFN-␥ or anti-TNF-␣ allophycocyanin (APC)-conjugated antibodies (BD Biosciences).
CD107a Degranulation Assay
CD107a degranulation assay was performed as described, 26 with minor modifications. Although CD107a degranulation is an indirect measure of cytotoxicity, it is now widely used to assess the cytotoxic potential of CD8 ϩ T cells and NK cells, 27 and it has been shown that there is a linear correlation between data obtained with the traditional 51 Cr release assay and the CD107a degranulation assay. 28 Briefly, after a 72-hour stimulation with different combinations of cytokines (IL-2ϩ IL-12 and IL-2ϩIL-21), PBMCs were washed and incubated for 3 hours at 37°C with K562 or P815 target cells (E:Tϭ1:1) in the presence of anti-CD107a PE antibody. Lytic activity was determined by flow cytometry and expressed as percentage of CD107a ϩ /CD56 ϩ /CD3 Ϫ NK. Moreover, redirected cytotoxicity experiments were set up in which PBMCs were cultured with Fc␥R ϩ P815 target cells, with or without mAb specific for the natural cytotoxicity receptors (NCRs) NKp30 and NKp46 and for NKG2D. 29 The latter approach allows binding of the mAb to P815 target cells via the immunoglobulin Fc␥ receptor and at the same time triggering of the lytic process through binding to the activating receptor expressed on effector cells. As for ICS, IL-21 was used in cytokine combinations because it was shown to augment NK cell proliferation and cytolytic activity. 23, 24 Original data illustrating positive and negative controls of the CD107a degranulation assay are included as Supplementary Figure 3 .
Statistical Analysis
The nonparametric Mann-Whitney U test was used to compare data, which were not normally distributed, between the different groups. Phenotypic and functional data are expressed as median percentage, 95% confidence interval (CI). Correlations between variables were analyzed using the Pearson correlation coefficient (r). A P value Յ .05 was deemed statistically significant.
Results
Peripheral Blood NK Cell Subsets in Patients With Chronic HBV and HCV Infections
The proportion of circulating NK cells was significantly lower in HCV ϩ and HBV ϩ patients compared with healthy subjects ( Figure 1A ). The frequency of NK cells expressing the NKG2C activating receptor was significantly higher in HBV-positive patients compared with HCV ϩ patients and healthy subjects ( Figure 1B ), whereas the frequency of NK cells expressing the NKG2D activating receptor was significantly increased in HCV ϩ patients compared with healthy controls ( Figure 1C ). Dot plots reporting staining with NKG2D-specific mAb and an isotype control in representative subjects are shown as Supplementary Figure 4 . The frequency of CD69 ϩ -activated NK cells was higher in HCV ϩ patients compared with HBV ϩ patients (P ϭ .044), even though both patient groups failed to show statistically significant differences with healthy subjects ( Figure 1D ). The observations showing increased proportions of NK cells expressing activation markers were supported by data on mean fluorescence intensity per cell, which was also increased (Supplementary Figure 5A-C) . Conversely, the proportion of NK cells expressing inhibitory receptors (INKRs), identified by a pool of monoclonal antibodies directed against KIR2DL1, KIR2DL2, KIR3DL1, and LIR1/ILT2, was significantly reduced in HCV ϩ but not in HBV ϩ patients compared with controls ( Figure 1E ). To identify which of the inhibitory receptor(s) was expressed at a lower level in patients with chronic HCV infection, we studied 17 patients with chronic HBV infection, 21 with chronic HCV infection, and 20 healthy donors, using single-receptor specific mAbs as detailed above. There was a statistically significant decrease in the proportion of KIR3DL1/DS1-expressing NK cells both in HCV-and HBV-infected patients (Figure 2A ). However, when the activating KIR3DS1 allele-expressing NK cells (defined as the dim fraction of CD158 e1,e2 positive cells identified by mAb Z27, Figure 2B ) were subtracted from analysis, the reduction remained significant in HCV-infected patients only ( Figure 2C ). Expression of the other inhibitory receptors did not differ from healthy donors ( Figure  2D-F) .
NKR expression on the CD56 dim NK cell subset broadly mirrored the differences between groups observed with the total NK cell population (Supplementary Figure 6A-E) . However, when the CD56 bright subset was considered for analysis, a statistically significant difference was only observed in the proportion of NKG2D ϩ cells, which, similarly to CD56 dim , was lower in HBV ϩ compared with HCV ϩ patients and in the proportion of NK cells expressing inhibitory receptors (data not shown).
NK Cytolytic Activity in Patients With Chronic HBV and HCV Infections
No statistically significant differences in the CD107a degranulation assay were observed using K562 target cells between healthy subjects and HBV-or HCVpositive patients in the absence of cytokine stimuli (data not shown). However, following stimulation with both combinations of cytokines, significantly decreased cytotoxicity compared with healthy donors was seen in HBV ϩ patients only (P ϭ .01 and P ϭ .019, after stimulation with IL-2ϩIL-12 and IL-2ϩIL-21, respectively; Supplementary Figure 7 ). Spontaneous cytotoxicity for P815 target cells in the absence of cytokines or triggering antibodies was significantly higher than healthy controls in HCV ϩ patients and to a much lesser extent in HBV ϩ subjects, which in both cases was restricted to the CD56 dim subset ( Figure 3A) . Stimulation with combinations of cytokines led to a statistically significant increase in cytolytic activity only in HCV ϩ patients compared with healthy subjects who showed levels of lytic activity comparable with HBV ϩ patients ( Figure 3B ). Representative original data are shown in Figure 3C . Redirected cytotoxicity experiments are shown on Figure 4 . Significantly increased degranulation was observed using anti-NKG2D and anti-NKp46 mAbs in both HCV ϩ and HBV ϩ patients, which again was exclusively restricted to the CD56 dim subset using anti-NKG2D mAb ( Figure 4A) . In HCV ϩ patients increased lytic activity was extended to CD56 bright NK cells using NKp46-and NKp30-specific mAbs, respec- tively ( Figure 4B and C) . Cytokine stimulation with IL-2ϩIL-12 produced a nonsignificant increase in cytotoxicity in HCV ϩ patients using NKp30 and NKp46 mAbs compared with healthy donors; however, following addition of IL-2ϩIL-21, the increment reached statistical significance ( Figure 5A and B) . NCR expression was similar in all patient categories (Supplementary Figure 8) , and there was no correlation between the proportion of NCRexpressing cells and redirected cytotoxicity using NCRs as triggering antibodies (not shown). Redirected cytotoxicity with anti-NKG2D mAb produced increased NK lytic activity using both cytokine combinations, which was restricted to the HCV ϩ patient group ( Figure 5C ). NK lytic activity in HBV ϩ patients was always comparable with that of healthy subjects, consistently and significantly lower than in HCV ϩ patients ( Figure 5A-C) . Differential analysis of the CD56 bright and CD56 dim subsets proved impossible after cytokine stimulation (not shown).
NK Cell Cytokine Production in Patients With Chronic HCV and HBV Infections
Patients with chronic HBV infection displayed significantly lower IFN-␥ and TNF-␣ production compared with healthy controls in all experimental conditions ( Figure 6A-D) . This was remarkably reproducible irrespective of the combination of cytokines used as stimulus and was evident in both CD56 dim and CD56 bright subsets. Patients with chronic HCV infection also showed reduced cytokine production, albeit to a lower extent than HBV ϩ patients. Indeed, IL-2ϩIL-12-stimulated NK 
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cells induced generally lower, although not significantly diminished, cytokine production except in the CD56 bright subset in which a statistically reduced TNF-␣ production was demonstrated ( Figure 6A and B) . However, when IL-2ϩIL-21 were used as stimulus, there was a statistically significant decrease in IFN-␥ and TNF-␣ production also in HCV ϩ patients, which was restricted to the CD56 dim subset ( Figure 6C and D) .
Biochemical, Histologic, and Virologic Correlates of NK Phenotype and Function
Several possible statistical correlations were sought between phenotype and function of NK cells, and biochemical (serum ALT, ␥-glutamil transpeptidase, ␥-globulin), or virologic (HCV genotype, serum HCV RNA or HBV DNA levels) indicators. In patients with chronic HCV infection, there was a statistically significant positive correlation between the proportion of activated (CD69 ϩ ) NK cells and serum alanine aminotransferase (ALT) as a surrogate marker of liver necroinflammation ( Figure 7A ), which was limited to the CD56 dim subset (Pearson, r ϭ 0.43; P ϭ .02). Also, there was a positive correlation between activated NK cells and serum HCV RNA values ( Figure 7B ), which was limited to the CD56 bright subset (Pearson, r ϭ 0.56; P ϭ .003). Interestingly, there was a statistically significant negative correlation between the proportion of NKG2D ϩ NK cells and ALT ( Figure 7C ). This NK subset appeared to concentrate in the liver as shown by findings indicating a substantial enrichment of NKG2D-positive cells in the intrahepatic compartment compared with the peripheral blood ( Figure 7D and E) . There was a positive correlation between frequencies of circulating and intrahepatic NKG2D-positive NK cells (Pearson, r ϭ 0.51, P ϭ .04). However, no direct correlation was found between total populations of peripheral and intrahepatic NK cells (not shown). No relevant statistical correlations were found with functional data, eg, CD107a degranulation and cytokine intracellular staining (not shown). Moreover, no correlations were found in patients with chronic HBV infection between NK phenotype and function and the indicators listed above (not shown).
Discussion
NK cells are tightly regulated by signals through a variety of stimulatory, costimulatory, and inhibitory receptors, which bind components of pathogens, host cells, or cytokines. 8 -10 In this study, we analyzed the expression of a large number of NK inhibitory and activating receptors and showed that there exist profound differences in NK cell phenotype and function between chronic HBV and HCV infections. In the latter, there was an increased proportion of NKG2D-expressing NK cells, which was also supported by mean fluorescence intensity data, and a concomitant decrease in those expressing inhibitory receptors, supporting the concept of a phenotype skewed toward activation, predominantly involving the NKG2D pathway. Instead, in the former, there was an increased proportion of NKG2C-expressing cells with normal inhibitory receptor expression, suggesting a more balanced activating/inhibitory receptor expression. Although single inhibitory receptor expression analysis clearly showed significantly decreased proportions of KIR3DL1/DS1-expressing NK cells in both HCV-and HBV-infected patients, reduction of the inhibitory KIR3DL1 alleleexpressing cells was only seen in HCV-positive patients, which identifies KIR3DL1/DS1 as a major candidate receptor involved in NK regulation in chronic HCV infection. Interestingly, KIR3DL1 has a long cytoplasmic tail that permits inhibitory signalling, whereas KIR3DS1 lacks the immunoreceptor tyrosine-based inhibition motif as other activating receptors and effectively functions as an activating receptor. 30, 31 KIR3DL1-and KIR3DS1-expressing cells can be easily identified as they segregate as different subsets of mAb Z27 bright and Z27 dim cells, respectively. 31 Expression of KIR3DS1 has been associated with delayed progression to AIDS and opportunistic infections, 32, 33 lending further support to the notion that it acts as activating receptor. Whether similar regulatory mechanisms are implicated in the progression of chronic hepatitis C requires further studies. In this experiment, a small fragment of a diagnostic liver biopsy specimen was mechanically disrupted and digested with collagenase IV and DNAse. Viable intrahepatic mononuclear cells were analysed by flow cytometry as described. 21 Differences in NKR expression were mirrored by clear functional differences. Whereas reduced NK cell frequencies did not affect spontaneous cytolytic effector function in agreement with previous studies, 12, 13, 34, 35 NK cells from HCV ϩ patients responded well to cytokine stimulation displaying normal or increased cytolytic activity towards K562 and P815 target cells, respectively, at variance with data suggesting that HCV envelope proteins impair NK cell activation and function 14, 15 and consistent with recently published findings indicating that culture-derived infectious HCV particles do not affect NK function. 36 This was further confirmed in the redirected cytotoxicity assay, which clearly showed that HCV infection is able to enhance NK cytotoxicity mainly through the NKG2D pathway and that NCRs, such as NKp30 and NKp46, are also involved despite apparently not being expressed at levels higher than healthy donors. Instead, patients with chronic HBV infection displayed normal or even lower cytotoxic activity for P815 and K562 targets, respectively, upon cytokine stimulation compared with patients with chronic HCV infection and healthy subjects, and, in keeping with this observation, redirected killing was indistinguishable from healthy donors. In this respect, our findings disagree with studies that showed deficient NK cytolytic activity in HCV-infected subjects 14 -19 but are in agreement with several others showing conserved cytotoxic potential. 12, 13, 34, 35 The reasons for such discrepancies are not immediately apparent, although they may be due, in part, to clinical, biochemical, and virologic heterogeneity of patients, for which we have attempted to control by performing an extended phenotypic and functional analysis in a substantial number of unselected patients and healthy donors.
The CD69 early activation antigen 37 was expressed in a higher proportion of NK cells from HCV ϩ patients compared with HBV ϩ patients, possibly explaining differences in the effector cytotoxic potential observed in the 2 patient groups. Interestingly, in HCV ϩ patients, the proportion of CD69 ϩ /CD56 dim NK cells correlated with serum ALT, a surrogate marker of liver necroinflammation, suggesting that mature activated NK cells are involved in liver immunopathology in this setting. Moreover, the direct correlation between serum HCV RNA levels and CD69 ϩ NK (CD56 bright ) cells would be compatible with the observation that HCV replication is responsible for activation of this NK cell subset during chronic infection as shown by others, 13 although we were unable to confirm the reported increase in IFN-␥ production by these cells.
The frequencies and phenotype of the CD56 dim NK cells and their degranulation capacity in the absence of cytokine stimuli broadly reflected the results obtained with the total NK cell population and emphasized their propensity toward cytolytic function, 8 -10 although, in HCV-infected patients, significant redirected cytotoxicity could be documented also in the CD56 bright subset. However, stimulation with cytokines conferred IFN-␥ and TNF-␣ production ability to both subsets, suggesting that the broadly accepted functional differences between the 2 subsets may not be so rigid, at least in this in vitro system.
The finding of a negative correlation between circulating NKG2D ϩ NK cells and ALT in patients with chronic HCV suggests homing of these cells to the liver where they may exert effector cytotoxic function, as supported by our preliminary findings demonstrating that NKG2D ϩ NK cells are highly enriched in the intrahepatic compartment. NKG2D belongs to the II C-type lectinlike family of transmembrane proteins and functions both as an activating and costimulatory receptor serving a fundamental role in the surveillance against microbial infections and cancer. 38, 39 The natural ligands for NKG2D are major histocompatibility complex class I chain-related proteins A and B (MICA and -B), which are stress inducible, nonclassical class I molecules, both of which can activate NK cells, 40 and members of the retinoic acid early inducible RAE-1 protein family, some of which were initially characterized as ligands for the CMV UL16 protein. 41 Interestingly, interaction of NKG2D with RAE-1 on hepatocytes in a transgenic mouse model of HBV infection was found to be an important recognition pathway of experimental NK cell-mediated liver injury. 42 However, expression of NKG2D ligands in the healthy and diseased human liver is only partially known in the case of MICA 43 and notably lacking in the case of RAE-1. Studies addressing this issue are currently in progress in our laboratory.
While differences in the cytotoxic potential between HBV ϩ and HCV ϩ patients were robust and reproducible, IFN-␥ and TNF-␣ production following stimulation with different cytokine combinations was shown to be dysfunctional also in HCV ϩ patients, even though to a lesser extent than in HBV ϩ patients. Different cytokine combinations seemed to account for different responses. Indeed, the presence of IL-21 proved to be a weaker stimulus in combination with IL-2 compared with IL-2ϩIL-12, which maintained IFN-␥ and TNF-␣ production at a lower, although statistically comparable, level than that of healthy donors.
Collectively, our data provide evidence for a functional dichotomy in chronic HCV infection, with a clearly enhanced basal and cytokine-induced lytic activity and a reduced TNF-␣ and IFN-␥ production, a functional defect that was definitely more profound in the setting of chronic HBV infection. The biologic consequences of dysfunctional cytokine production in chronic hepatitis C would be that HCV persists in the host in the face of an enhanced NK cytotoxic activity. Indeed, IFN-␥ production has been shown to be a powerful non-cytolytic mechanism of viral clearance from infected hepatocytes, 44 and it can specifically inhibit HCV replication in vitro. 45, 46 Interestingly, IFN-␥ production by virus-spe-cific T cells is also significantly impaired during chronic HCV infection, 47, 48 adding to the concomitant NK cell defect we have demonstrated here. TNF-␣, instead, appears to be inefficient in controlling HCV replication as shown in replicon-containing hepatoma cells compared with IFN-␥, 49 but it seems to be a key mediator in HBV persistence because of its direct antiviral effect 44 and because it is essential for the proliferation of HBV-specific cytotoxic T cells. 50 Moreover, patients treated with TNF-␣ inhibitors may incur a severe reactivation of chronic hepatitis B, adding further evidence in support of the importance of this cytokine in HBV control. 51 The markedly defective NK cytokine production in the context of a relatively normal or reduced (in the case of K562 target cells) NK cytolytic activity only in HBV infection presumably reflects the poor cellular response to type I IFN-inducible genes in this condition 1 and suggests that the previously reported mechanism of cytokine-induced tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated NK cell killing of hepatocytes probably occurs predominantly during liver inflammatory flares, 52 which are typically observed in this setting. 53 In conclusion, our study revealed previously unappreciated findings in patients with chronic HBV and HCV infections, featuring conserved or enhanced cytolytic activity and dysfunctional cytokine production, which may be a key factor contributing to virus persistence and chronic liver immunopathology.
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